VRG Therapeutics
Company

VRG Therapeutics

Biotechnology Research Hu 28 employees
Employees
28
Contacts
2
Emails
2

VRG Therapeutics Overview

Headquarters
Hu
Industry
Biotechnology Research
Employees
28
Founded
2023
Funding
5.5M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About VRG Therapeutics

Our mission is to cure diseases via targets and MoAs that cannot be reached with traditional approaches. Leveraging our unique platform, we optimize peptides/proteins of natural origin using directed evolution to create cutting-edge CGT products or peptide-based pharmaceuticals. VRGT’s management and staff members were selected based on their international research experience and outstanding pharma industry achievements. Our people have outstanding professional expertise in preclinical/clinical R&D and scientific project management, pharmacology, business development and medical marketing. For years, they have worked in the most prestigious academic institutes, such as Fred Hutchinson Cancer Research Center, Karolinska Institute, Harvard University, Weizmann Institute of Science and several leading pharma companies.

VRG Therapeutics Contact Details

People in AeroLeads
3
With contact data
2
Email contacts
2
66.7% coverage

VRG Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Hristos Glavinas External Consultant at Vrg Therapeutics
View
Peter Puskas Chief Executive Officer at Sycamore
Email
Tamás Kitka Managing Director of Create Therapeutics
Email

Employees by Management Level

Executive 1 profile
Director 1 profile
Individual contributor 1 profile

Compare Similar Companies to VRG Therapeutics